Weight | 1 lbs |
---|---|
Dimensions | 9 × 5 × 2 in |
host | mouse |
isotype | IgG |
clonality | monoclonal |
concentration | concentrate, predilute |
applications | IHC |
reactivity | human |
available size | 0.1 mL, 0.5 mL, 1 mL concentrated, 7 mL prediluted |
rabbit anti-HBsAg monoclonal antibody (ZR393) 6209
$160.00 – $528.00
Antibody summary
- Rabbit monoclonal to Hepatitis B Virus (HBV) HBsAg
- Suitable for: Immunohistochemistry (formalin-fixed, paraffin-embedded tissues)
- Reacts with: Human
- Isotype:IgG
- Control: Hepatitis B infected liver
- Visualization: Cytoplasmic
- 0.1, 0.5, 1.0 mL concentrated, 7 mL prediluted
rabbit anti-HBsAg monoclonal antibody ZR393 6209
target relevance |
---|
Protein names Large envelope protein (L glycoprotein) (L-HBsAg) (LHB) (Large S protein) (Large surface protein) (Major surface antigen) |
Gene names S,S |
Protein family Orthohepadnavirus major surface antigen family |
Mass 43669Da |
Function #N/A |
Subellular location #N/A |
Structure SUBUNIT: [Isoform L]: In its internal form (Li-HBsAg), interacts with the capsid protein and with the isoform S. Interacts with host chaperone CANX. {ECO:0000250|UniProtKB:P03141}.; SUBUNIT: [Isoform M]: Associates with host chaperone CANX through its pre-S2 N glycan; this association may be essential for isoform M proper secretion. {ECO:0000250|UniProtKB:P03141}.; SUBUNIT: [Isoform S]: Interacts with isoform L. Interacts with the antigens of satellite virus HDV (HDVAgs); this interaction is required for encapsidation of HDV genomic RNA. {ECO:0000250|UniProtKB:P03141}. |
Post-translational modification PTM: Isoform M is N-terminally acetylated by host at a ratio of 90%, and N-glycosylated by host at the pre-S2 region. {ECO:0000250|UniProtKB:P03138, ECO:0000255|HAMAP-Rule:MF_04075}.; PTM: Myristoylated. {ECO:0000255|HAMAP-Rule:MF_04075}. |
Domain #N/A |
Biotechnology BIOTECHNOLOGY: Systematic vaccination of individuals at risk of exposure to the virus has been the main method of controlling the morbidity and mortality associated with hepatitis B. The first hepatitis B vaccine was manufactured by the purification and inactivation of HBsAg obtained from the plasma of chronic hepatitis B virus carriers. The vaccine is now produced by recombinant DNA techniques and expression of the S isoform in yeast cells. The pre-S region do not seem to induce strong enough antigenic response. |
Target Relevance information above includes information from UniProt accession: Q76R62 |
The UniProt Consortium |
Data
![]() |
Human liver infected by hepatitis B virus stained with anti-HBsAg antibody using peroxidase-conjugate and DAB chromogen. Note the cytoplasmic staining of infected hepatocytes. |
Publications
Publications
pmid | title | authors | citation |
---|---|---|---|
We haven't added any publications to our database yet. |
Protocols
relevant to this product |
---|
IHC |
Documents
# | SDS | Certificate | |
---|---|---|---|
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. |